Search

The objective: to determine the state and prospects of TB control services including the period during the COVID-19 pandemic.Materials. Data from Federal Statistic Surveillance Forms no. 4, 8, 14, 14-DS, 30, 33, 47, and 61 were analyzed. The number of those died is presented as per the data of Rosstat.Research methods: epidemiological and statistical analysis, expert assessment, and content analysis of publications and regulations.Results. In Russia in the second decade of the XXI century, there was a significant improvement of tuberculosis situation. From 2010 to 2019, the reduction of the rates was the following: incidence – from 77.2 to 41.2 per 100,000 population (by 46.6%); prevalence – from 177.5 to 86.4 per 100,000 population (by 51.3%); mortality – from 15.4 to 5.1 per 100,000 population (3-fold reduction).In recent years, one can anticipate the stabilization of HIV situation. Over 10 years (2006-2015), the average growth rate of indicators was the following: incidence – by 9.8%, prevalence at the end of the year – by 9.4%, mortality – by 26.6%. In 2016-2019, HIV incidence became stable (2019 – 54.6 per 100,000 population). In 2019, for the first time HIV mortality decreased by 2.1% and reached 13.7 per 100,000 population. The number of lethal TB/HIV co-infection cases is going down. People at the age of 15-34 fall ill (2019 – 37.6%) and die (23.6%) less often versus all new cases and those who died of HIV infection. Russia has the highest coverage of the population with HIV tests (28.5%).Epidemics of tuberculosis and coronavirus infection are developing in the opposite directions. High rates of COVID-19 are observed in regions with low tuberculosis rates, therefore the COVID-19 pandemic will not result in the increase of tuberculosis incidence in the population that is predominantly not infected with tuberculosis. Conversely, in regions with a high level of tuberculosis infection in the population, the number of coronavirus cases is significantly lower.In Russia, in the near future COVID-19 will not contribute to the increase in incidence and mortality of tuberculosis and HIV infection. The negative effects of the pandemic are partially offset by a sharp reduction in contacts, an increase in lung computed tomography, regular supply of anti-tuberculosis and antiretroviral drugs purchased by the state budgets of different levels, improved patients’ adherence to treatment, and the expansion of hospital-replacing technologies in specialized medical organizations.Facilities, resources and personnel of medical TB control services make it possible to expand their functions to fulfill the goals and objectives of the RF Healthcare Development Strategy for the period up to 2025 for socially significant infectious diseases that pose a biological threat to the population (tuberculosis, HIV infections, and parenteral viral hepatitis).

The objective: to describe the current state of tuberculosis situation before the start of the national healthcare project which is to be implemented till 2024. Materials. The data from Federal Statistics Forms no. 8, 33, and 61. The number of those died is presented as per the data of Rosstat. Epidemiological rates were calculated as per mi d-y ear population. Results. In Russia, tuberculosis situation has stabilized and there is a tendency for its improvement, and the changes in main tuberculosis rates provide the evidence of the above. For 10 years (from 2008 to 2017) the following main tuberculosis rates went down: tuberculosis incidence – from 85.1 to 48.3 per 100,000 pop. (by 43.2%); tuberculosis incidence among children from 0 to 14 years old – from 15.3 to 9.7 per 100,000 pop. (by 36.6%); tuberculosis prevalence by the end of the year – from 190.7 to 109.8 per 100,000 pop. (by 42.4%); bacillary excretion in tuberculosis patients – from 80.3 to 46.0 per 100,000 pop. (by 42.7%); tuberculosis mortality – from 17.9 to 6.5 per 100,000 pop. (by 63.7%). In 2017, tuberculosis incidence among resident population, HIV negative (33.4), was lower than the minimum rate, which was registered in Russia in 1991, when HIV infection provided no significant impact on tuberculosis situation in the country (34.0 per 100.000 pop.). in 2017, tuberculosis mortality (6.5 per 100,000 pop.) which hardly now includes those HIV infected and died of tuberculosis, is lower than the minimum rate documented in 1989 (7.4 per 100,000). In the long view, the developing HIV epidemics will provide a negative impact on tuberculosis situation given the growing rates of the patients at the advanced stages of HIV infection and the increasing number of patients with multiple drug resistance. HIV infection will not allow achieving a significant reduction of tuberculosis incidence and will result in the growing fatality among tuberculosis patients in the number of the regions of the Russian Federation. Currently, it is not necessary to concentrate on the number of those examined but to improve the quality of screening in the groups facing a high risk to develop tuberculosis and to consider r e-o rganization of tuberculosis services due to the reduction of tuberculosis incidence. During 10 years (201 8-2 027), tuberculosis incidence is to be reduced twice. The program for tuberculosis incidence reduction is to be predicted for each region specifically, considering the current tuberculosis situation and the level of tuberculosis detection organization. In parallel, the effective tuberculosis care is to be provided for those HIV infected.